| Dr Daniel H Petroni, MD, PHD | |
|
9725 3rd Ave Ne, Suite 500, Seattle, WA 98115-2060 | |
| (206) 527-1200 | |
| (206) 523-0724 |
| Full Name | Dr Daniel H Petroni |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 13 Years |
| Location | 9725 3rd Ave Ne, Seattle, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073808028 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 60484134 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Asthma And Allergy Center | 6507759743 | 15 |
News Archive
During labor and delivery, infants preferentially secrete a different stress hormone than their mothers do, according to a new clinical study. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco and published in the open access journal, PLoS One.
The Medical Entrepreneur Pearls, Pitfalls and Practical Business Advice for Doctors (Nano 2.0 Business Press 2010) was written to help physicians, residents and medical students prepare for the business side of private practice. "In medical school curricula there is barely enough time to cover all the necessary medical courses so there certainly is no room for teaching the business of medicine," says Dr. Steven Hacker, author of The Medical Entrepreneur and a successful physician entrepreneur.
It's long been known that people living with HIV experience a loss of white matter in their brains. As opposed to "gray matter," which is composed of the cell bodies of neurons, white matter is made up of a fatty substance called myelin that coats neurons, offering protection and helping them transmit signals quickly and efficiently.
Janssen Research & Development, LLC (Janssen) today announced patients are now enrolling in a multicenter, open-label expanded access program (EAP) in the United States for the investigational oral Bruton's Tyrosine Kinase (BTK) inhibitor ibrutinib, which is being jointly developed by Janssen and Pharmacyclics, Inc.
The Wistar Institute was awarded two major grants totaling more than $12 million from the National Institute on Drug Abuse, part of the National Institutes of Health, to fund an international multidisciplinary clinical research consortium spearheaded by Wistar's HIV Research Program.
› Verified 8 days ago
| Entity Name | The Association Of University Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023041159 PECOS PAC ID: 0446162697 Enrollment ID: O20031105000244 |
News Archive
During labor and delivery, infants preferentially secrete a different stress hormone than their mothers do, according to a new clinical study. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco and published in the open access journal, PLoS One.
The Medical Entrepreneur Pearls, Pitfalls and Practical Business Advice for Doctors (Nano 2.0 Business Press 2010) was written to help physicians, residents and medical students prepare for the business side of private practice. "In medical school curricula there is barely enough time to cover all the necessary medical courses so there certainly is no room for teaching the business of medicine," says Dr. Steven Hacker, author of The Medical Entrepreneur and a successful physician entrepreneur.
It's long been known that people living with HIV experience a loss of white matter in their brains. As opposed to "gray matter," which is composed of the cell bodies of neurons, white matter is made up of a fatty substance called myelin that coats neurons, offering protection and helping them transmit signals quickly and efficiently.
Janssen Research & Development, LLC (Janssen) today announced patients are now enrolling in a multicenter, open-label expanded access program (EAP) in the United States for the investigational oral Bruton's Tyrosine Kinase (BTK) inhibitor ibrutinib, which is being jointly developed by Janssen and Pharmacyclics, Inc.
The Wistar Institute was awarded two major grants totaling more than $12 million from the National Institute on Drug Abuse, part of the National Institutes of Health, to fund an international multidisciplinary clinical research consortium spearheaded by Wistar's HIV Research Program.
› Verified 8 days ago
| Entity Name | Seattle Children's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003319500 PECOS PAC ID: 9032021050 Enrollment ID: O20031211000532 |
News Archive
During labor and delivery, infants preferentially secrete a different stress hormone than their mothers do, according to a new clinical study. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco and published in the open access journal, PLoS One.
The Medical Entrepreneur Pearls, Pitfalls and Practical Business Advice for Doctors (Nano 2.0 Business Press 2010) was written to help physicians, residents and medical students prepare for the business side of private practice. "In medical school curricula there is barely enough time to cover all the necessary medical courses so there certainly is no room for teaching the business of medicine," says Dr. Steven Hacker, author of The Medical Entrepreneur and a successful physician entrepreneur.
It's long been known that people living with HIV experience a loss of white matter in their brains. As opposed to "gray matter," which is composed of the cell bodies of neurons, white matter is made up of a fatty substance called myelin that coats neurons, offering protection and helping them transmit signals quickly and efficiently.
Janssen Research & Development, LLC (Janssen) today announced patients are now enrolling in a multicenter, open-label expanded access program (EAP) in the United States for the investigational oral Bruton's Tyrosine Kinase (BTK) inhibitor ibrutinib, which is being jointly developed by Janssen and Pharmacyclics, Inc.
The Wistar Institute was awarded two major grants totaling more than $12 million from the National Institute on Drug Abuse, part of the National Institutes of Health, to fund an international multidisciplinary clinical research consortium spearheaded by Wistar's HIV Research Program.
› Verified 8 days ago
| Entity Name | Northwest Asthma & Allergy Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760620462 PECOS PAC ID: 6507759743 Enrollment ID: O20040209000462 |
News Archive
During labor and delivery, infants preferentially secrete a different stress hormone than their mothers do, according to a new clinical study. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco and published in the open access journal, PLoS One.
The Medical Entrepreneur Pearls, Pitfalls and Practical Business Advice for Doctors (Nano 2.0 Business Press 2010) was written to help physicians, residents and medical students prepare for the business side of private practice. "In medical school curricula there is barely enough time to cover all the necessary medical courses so there certainly is no room for teaching the business of medicine," says Dr. Steven Hacker, author of The Medical Entrepreneur and a successful physician entrepreneur.
It's long been known that people living with HIV experience a loss of white matter in their brains. As opposed to "gray matter," which is composed of the cell bodies of neurons, white matter is made up of a fatty substance called myelin that coats neurons, offering protection and helping them transmit signals quickly and efficiently.
Janssen Research & Development, LLC (Janssen) today announced patients are now enrolling in a multicenter, open-label expanded access program (EAP) in the United States for the investigational oral Bruton's Tyrosine Kinase (BTK) inhibitor ibrutinib, which is being jointly developed by Janssen and Pharmacyclics, Inc.
The Wistar Institute was awarded two major grants totaling more than $12 million from the National Institute on Drug Abuse, part of the National Institutes of Health, to fund an international multidisciplinary clinical research consortium spearheaded by Wistar's HIV Research Program.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel H Petroni, MD, PHD 9725 3rd Ave Ne, Suite 500, Seattle, WA 98115-2060 Ph: (206) 527-1200 | Dr Daniel H Petroni, MD, PHD 9725 3rd Ave Ne, Suite 500, Seattle, WA 98115-2060 Ph: (206) 527-1200 |
News Archive
During labor and delivery, infants preferentially secrete a different stress hormone than their mothers do, according to a new clinical study. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco and published in the open access journal, PLoS One.
The Medical Entrepreneur Pearls, Pitfalls and Practical Business Advice for Doctors (Nano 2.0 Business Press 2010) was written to help physicians, residents and medical students prepare for the business side of private practice. "In medical school curricula there is barely enough time to cover all the necessary medical courses so there certainly is no room for teaching the business of medicine," says Dr. Steven Hacker, author of The Medical Entrepreneur and a successful physician entrepreneur.
It's long been known that people living with HIV experience a loss of white matter in their brains. As opposed to "gray matter," which is composed of the cell bodies of neurons, white matter is made up of a fatty substance called myelin that coats neurons, offering protection and helping them transmit signals quickly and efficiently.
Janssen Research & Development, LLC (Janssen) today announced patients are now enrolling in a multicenter, open-label expanded access program (EAP) in the United States for the investigational oral Bruton's Tyrosine Kinase (BTK) inhibitor ibrutinib, which is being jointly developed by Janssen and Pharmacyclics, Inc.
The Wistar Institute was awarded two major grants totaling more than $12 million from the National Institute on Drug Abuse, part of the National Institutes of Health, to fund an international multidisciplinary clinical research consortium spearheaded by Wistar's HIV Research Program.
› Verified 8 days ago
Sana Patel, Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 4500 40th Ave Ne, Seattle, WA 98105 Phone: 206-987-8811 | |
Susan S Xie, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 2671 Ne 46th St, Seattle, WA 98105 Phone: 206-525-8000 Fax: 206-525-8070 | |
Timothy J. Baltz, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 200 15th Ave E, Seattle, WA 98112 Phone: 206-326-3000 | |
Ashley M Jerath Tatum, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 9725 3rd Ave Ne Ste 500, Seattle, WA 98115 Phone: 206-527-1200 Fax: 206-527-2514 | |
John B. Yuen, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1101 Madison St, Suite 301, Seattle, WA 98104 Phone: 206-505-1104 | |
Frank S Virant, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 9725 3rd Ave Ne Ste 500, Seattle, WA 98115 Phone: 206-527-1200 Fax: 206-527-2514 |